Supplementary Table S1 from Lisaftoclax in Combination with Alrizomadlin Overcomes Venetoclax Resistance in Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia: Preclinical Studies

Authors :: Dajun Yang
Feng Zhou
Na Li
Sheng-Li Xue
Chengcheng Fu
Yan Yin
Qixin Wang
Kaixiang Zhang
Jing Deng
Douglas D. Fang
Qiuqiong Tang
Yifan Zhai
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Table 1. Clinical characteristics of patients with relapsed or refractory acute myeloid leukemia.

Tools